Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer

Japanese Journal of Clinical Oncology

Volumn 38, Issue 6, 2008, Pages 419-425

  Taira, Naruto ^a   Ohsumi, Shozo ^b   Takabatake, Daisuke ^b   Hara, Fumikata ^b   Takashima, Seiki ^b   Aogi, Kenjiro ^b   Takashima, Shigemitsu ^b   Inoue, Takeshi ^b   Sugata, Shigenori ^b   Nishimura, Rieko ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Breast CT; IEBN; Malignancy; MRI; Occult lesion; Preoperative

Indexed keywords

IOPAMIDOL; IOPAMILONE; CONTRAST MEDIUM;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CANCER; OCCULT CANCER; PREOPERATIVE EVALUATION; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TUMOR VOLUME; CANCER OF UNKNOWN PRIMARY SITE; FEMALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, UNKNOWN PRIMARY; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46349100889     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn040     Document Type: Article

References (27)

1. Esserman L, Hylton N, George T, Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 1999;5:13-21.
2. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999; 17:110-9.
3. Voogd AC, Peterse JL, Crommelin MA, Rutgers EJ, Botke G, Elkhuizen PH, et al. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST). Eur J Cancer 1999;35:1828-37.
4. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668-75.
5. Amano G, Ohuchi N, Ishibashi T, Ishida T, Amari M, Satomi S. Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast. Breast Cancer Res Treat 2000;60:43-55.
6. Van Goethem M, Schelfout K, Kersschot E, Colpaert C, Verslegers I, Bilties I, et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007;62:273-82.
7. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;233:830-49.
8. Zhang Y, Fukatsu H, Naganawa S, Satake H, Sato Y, Ohiwa M, et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer 2002;9: 231-9.
9. Hiramatsu, H, Enomoto K, Ikeda T, Mukai M, Furuta T, Hattori H, et al. Three-dimensional helical CT for treatment planning of breast cancer. Radiat Med 1999; 17:35-40.
10. Akashi-Tanaka S, Fukutomi T, Miyakawa K, Uchiyama N, Tsuda H. Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer. Breast Cancer Res Treat 1998;49:79-86.
11. Uematsu T, Sano M, Homma K, Shiina M, Kobayashi S. Three-dimensional helical CT of the breast: Accuracy for measuring extent of breast cancer candidates for breast conserving surgery. Breast Cancer Res Treat 2001;65:249-57.
12. Nishino M, Hayakawa K, Yamamoto A, Nakamura Y, Morimoto T, Mukaihara S, et al. Multiple enhancing lesions detected on dynamic helical computed tomography-mammography. J Comput Assist Tomogr 2003;27:771-8.
13. Nakahara H, Namba K, Wakamatsu H, Watanabe R, Furusawa H, Shirouzu M, et al. Extension of breast cancer: Comparison of CT and MRI. Radiat Med 2002;20:17-23.
14. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials ofbreast-conserving surgery. Cancer 1985;56:979-90.
15. Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, et al. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115 -22.
16. Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes T, et al. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743-7.
17. Fischer U, Kopka L, Grabbe E. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881-8.
18. Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W, Kissin MW, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997;169:417-24.
19. Krämer S, Schulz-Wendtland R, Hagedorn K, Bautz W, Lang N. Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer. Anticancer Res 1998;18:2163-4.
20. Weinstein SP, Orel SG, Heller R, Reynolds C, Czerniecki B, Solin LJ, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 2001;176:399-406.
21. Schnall MD, Blume J, Bluemke DA, Deangelis GA, Debruhl N, Harms S, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005;92:32-8.
22. Liberman L, Morris EA, Kim CM, Kaplan JB, Abramson AF, Menell JH, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003;180:333-41.
23. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, et al., ACRIN Trial 6667 Investigators Group.MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356:1295-303.
24. Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007;243:670-80.
25. Fischer U, Zachariac O, Baum F, von Heyden D, Funke M, Liersch T, The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004;14:1725-31.
26. Berrington de González A, Darby S. Risk of cancer from diagnostic X-rays: Estimates for the UK and 14 other countries. Lancet 2004;363:345-51.
27. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007:357:2277-84.